Bilal is a Trainee Market Access professional at Biogen, specializing in health economics and early benefit assessment of pharmaceuticals. He holds an M. Sc. in Health Economics from FAU Erlangen-Nürnberg and a B. Sc. from Rosenheim Technical University of Applied Sciences.
Bilals academic background includes extensive work in systematic reviews for AMNOG procedures and data extraction from clinical study reports. His professional experience also covers quality assurance in biopharmaceutical product release.
He developed and validated a Tableau query to support batch release processes at Boehringer Ingelheim.
Bilal Elkashef
Trainee Market Access at Biogen
Munich, Bavaria, Germany
Overview
Topics They Care About
Market Access Strategy
As a Trainee Market Access at Biogen, Bilal is actively involved in the strategies for bringing new pharmaceuticals to market.
Health Economics
Bilal holds an M. Sc. in Health Economics and applied this expertise in supporting dossiers for early benefit assessment of drugs.
HTA & Value Demonstration
His previous role at IGES Institut GmbH focused on Health Technology Assessment and value demonstration for pharmaceuticals.
Media Appearances
Bilal has no verified media appearances
Work History
2-2026
Trainee Market Access at Biogen
11-2023 - 12-2025
Studentischer Mitarbeiter im Bereich HTA & Value Demonstration at IGES Institut GmbH
2-2022 - 8-2022
Quality Assurance Specialist at Boehringer Ingelheim
9-2021 - 1-2022
Praktikant im Bereich QA - Product Release at Boehringer Ingelheim
9-2017 - 7-2018
Freiwilliges Soziales Jahr at Österreichische Blindenwohlfahrt
Education
Master of Science - MS from FAU Erlangen-Nürnberg
Bachelor of Science - BS from Rosenheim Technical University of Applied Sciences
More Information
Social Presence :
Prographics :
Exp : 3
Location : Munich, Bavaria, Germany
Job Level : N/A
Designation : Trainee Market Access at Biogen
